Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 08-2025 | 05-2025 | 02-2025 | 11-2024 | 08-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -186,236 | -99,815 | -56,351 | -193,569 | -135,020 |
| Depreciation Amortization | 14,225 | 9,225 | 4,128 | 5,140 | 12,125 |
| Accounts receivable | N/A | -19,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -3,655 | -5,888 | -3,209 | 5,209 | -2,376 |
| Other Working Capital | -30,046 | -46,507 | -14,029 | -18,401 | -18,850 |
| Other Operating Activity | 24,079 | 37,737 | 8,374 | 29,037 | 20,288 |
| Operating Cash Flow | $-181,633 | $-124,248 | $-61,087 | $-172,584 | $-123,833 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,871 | -6,160 | -3,485 | -9,273 | -7,168 |
| Purchase Of Investment | -281,350 | -178,351 | -110,183 | -707,953 | -409,738 |
| Sale Of Investment | 437,728 | 281,543 | 139,201 | 459,513 | 300,010 |
| Investing Cash Flow | $147,507 | $97,032 | $25,533 | $-257,713 | $-116,896 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,634 | 1,479 | 1,473 | 296,950 | 285,161 |
| Common Stock Repurchased | 0 | N/A | N/A | -15 | -15 |
| Other Financing Activity | 0 | 0 | 0 | 188,732 | 0 |
| Financing Cash Flow | $2,634 | $1,479 | $1,473 | $485,667 | $285,146 |
| Beginning Cash Position | 110,898 | 110,898 | 110,898 | 55,528 | 55,528 |
| End Cash Position | 79,406 | 85,161 | 76,817 | 110,898 | 99,945 |
| Net Cash Flow | $-31,492 | $-25,737 | $-34,081 | $55,370 | $44,417 |
| Free Cash Flow | |||||
| Operating Cash Flow | -181,633 | -124,248 | -61,087 | -172,584 | -123,833 |
| Capital Expenditure | -8,871 | -6,160 | -3,485 | -9,273 | -7,168 |
| Free Cash Flow | -190,504 | -130,408 | -64,572 | -181,857 | -131,001 |